Logo do repositório
 
Miniatura
Publicação

If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study

2021-11Artigo científico Acesso aberto
http://hdl.handle.net/10400.16/2846
Utilize este identificador para referenciar este registo.
Nome:Descrição:Tamanho:Formato: 
Beldman-2021.pdf586.58 KBAdobe PDF Ver/Abrir

Autores

Beldman, Mark
Löwik, Claudia
Soriano, Alex
Albiach, Laila
Zijlstra, Wierd P
Knobben, Bas A S
Jutte, Paul
Carvalho, André
Goswami, Karan

Orientador(es)

Resumo(s)

Background: Rifampin is generally advised in the treatment of acute staphylococcal periprosthetic joint infections (PJI). However, if, when, and how to use rifampin remains a matter of debate. We evaluated the outcome of patients treated with and without rifampin, and analyzed the influence of timing, dose and co-antibiotic. Methods: Acute staphylococcal PJIs treated with surgical debridement between 1999 and 2017, and a minimal follow-up of 1 year were evaluated. Treatment failure was defined as the need for any further surgical procedure related to infection, PJI-related death or the need for suppressive antimicrobial treatment. Results: A total of 669 patients were analyzed. Treatment failure was 32.2% (131/407) in patients treated with rifampin and 54.2% (142/262) in whom rifampin was withheld (P < .001). The most prominent effect of rifampin was observed in knees (treatment failure 28.6% versus 63.9%, respectively, P < .001). The use of rifampin was an independent predictor of treatment success in the multi-variate analysis (OR 0.30, 95% CI 0.20 - 0.45). In the rifampin group, the use of a co-antibiotic other than a fluoroquinolone or clindamycin (OR 10.1, 95% CI 5.65 - 18.2) and the start of rifampin within 5 days after surgical debridement (OR 1.96, 95% CI 1.08 - 3.65) were predictors of treatment failure. The dosing of rifampin had no effect on outcome.

Descrição

Palavras-chave

acute failure periprosthetic joint infection rifampin staphylococci

URI

http://hdl.handle.net/10400.16/2846

Contexto Educativo

Citação

Beldman M, Löwik C, Soriano A, et al. If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study [published correction appears in Clin Infect Dis. 2022 May 30;74(10):1890]. Clin Infect Dis. 2021;73(9):1634-1641. doi:10.1093/cid/ciab426

Projetos de investigação

Unidades organizacionais

Fascículo

Editora

Oxford University Press

DOI

10.1093/cid/ciab426

Coleções

CC_SO_Artigos publicados em revistas indexadas na Pubmed/Medline

Licença CC

Métricas Alternativas